Orchard Therapeutics plc reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
London, United Kingdom
SEC filing record 1 source field available
Fiscal year end
31 December
Orchard Therapeutics plc has filed 339 SEC EDGAR filings since 06 Aug 2018

SEC filing history

Showing 101-125 of 339 matching filings.

Per page
25
Current page
5
SC 13G/A File 005-90710

SC 13G/A

Filing date
14 Nov 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Oct 2022
Reporting date
04 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Oct 2022
Reporting date
04 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-263967

424B5

Filing date
06 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-90710

SC 13G filing

Filing date
09 Sep 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-266507

S-8

Filing date
04 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Jun 2022
Reporting date
07 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Jun 2022
Reporting date
07 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Jun 2022
Reporting date
07 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Jun 2022
Reporting date
07 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Jun 2022
Reporting date
07 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Jun 2022
Reporting date
07 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Jun 2022
Reporting date
07 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Jun 2022
Reporting date
01 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Jun 2022
Reporting date
01 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90710

ORCHARD THERAPEUTICS PLC

Filing date
09 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-263967

EFFECT filing

Filing date
29 Apr 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .